January 1, 2025 - December 31, 2025
-
Consolidated Financial Summary (IFRS) Fiscal 2025 Second Quarter
(1,584KB)
-
Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2025 Second Quarter
(1,666KB)
-
Results Presentation Fiscal 2025 Second Quarter
(1,469KB)
-
Transcript of Results Briefing Fiscal 2025 Second Quarter
(3,312KB)
-
Revenues from other products
(14KB)
January 1, 2024 - December 31, 2024
-
Consolidated Financial Summary (IFRS) Fiscal 2024 Second Quarter
(667KB)
-
Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2024 Second Quarter
(995KB)
-
Results Presentation Fiscal 2024 Second Quarter
(1,805KB)
-
Transcript of Results Briefing Fiscal 2024 Second Quarter
(2,175KB)
-
Revenues from other products
(12KB)
January 1, 2023 - December 31, 2023
-
Consolidated Financial Summary (IFRS) Fiscal 2023
(846KB)
-
Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2023
(1,189KB)
-
Results Presentation Fiscal 2023
(1,720KB)
-
Transcript of Results Briefing Fiscal 2023
(3,858KB)
-
Revenues from other products
(12KB)
-
Annual Securities Report
(1,909KB)
-
Consolidated Financial Summary (IFRS) Fiscal 2023 Third Quarter
(674KB)
-
Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2023 Third Quarter
(1,125KB)
-
(Correction) Appendix to the Consolidated Financial Summary Fiscal 2023 Third Quarter
(304KB)
-
Results Presentation Fiscal 2023 Third Quarter
(1,071KB)
-
Transcript of Results Presentation Fiscal 2023 Third Quarter (text)
(2,293KB)
-
Consolidated Financial Summary (IFRS) Fiscal 2023 Second Quarter
(702KB)
-
Appendix to the Consolidated Financial Summary (IFRS) Fiscal 2023 Second Quarter
(930KB)
-
(Correction) Appendix to the Consolidated Financial Summary Fiscal 2023 Second Quarter
(130KB)
-
Results Presentation Fiscal 2023 Second Quarter
(1,183KB)
-
Transcript of Results Briefing Fiscal 2023 Second Quarter
(2,085KB)
-
Revenues from other products
(28KB)
January 1, 2022 - December 31, 2022
-
Consolidated Financial Summary (IFRS) Fiscal 2022
(818KB)
-
Appendix to the Consolidated Financial Summary Fiscal 2022
(1,443KB)
-
Results Presentation Fiscal 2022
(1,118KB)
-
Transcript of Results Briefing Fiscal 2022
(2,974KB)
-
Revenues from other products
(27KB)
-
Annual Securities Report
(1,814KB)
January 1, 2021 - December 31, 2021
-
Consolidated Financial Summary Fiscal 2021 Second Quarter
(720KB)
-
Appendix to the Consolidated Financial Summary Fiscal 2021 Second Quarter
(889KB)
-
Results Presentation Fiscal 2021 Second Quarter
(566KB)
-
Revenues from other products
(25KB)
-
Transcript of Results Briefing Fiscal 2021 Second Quarter (text)
(1,500KB)
January 1, 2020 - December 31, 2020
-
Consolidated Financial Summary Fiscal 2020
(601KB)
-
Appendix to the Consolidated Financial Summary Fiscal 2020
(345KB)
-
Results Presentation Fiscal 2020
(448KB)
-
Summary of late-stage clinical trials
(566KB)
-
Revenues from other products
(25KB)
-
Transcript of FY 2020 Results/2021-2025 Medium Term Business Plan Briefing (text)
(2,712KB)
-
Consolidated Financial Summary Fiscal 2020 Interim
(2,121KB)
-
Appendix to the Consolidated Financial Summary Fiscal 2020 Interim
(573KB)
-
Results Presentation Fiscal 2020 Interim
(735KB)
-
Summary of clinical trials
(627KB)
-
Revenues from other products
(22KB)
-
Transcript of Results Presentation Fiscal 2020 Interim (text)
(1,274KB)
January 1, 2019 - December 31, 2019
-
Consolidated Financial Summary Fiscal 2019
(452KB)
-
Appendix to the Consolidated Financial Summary Fiscal 2019
(765KB)
-
Results Presentation Fiscal 2019
(1,045KB)
-
Summary of late-stage clinical trials
(187KB)
-
Revenues from other products
(23KB)
-
Transcript of Results Presentation Fiscal 2019 (text)
(1,499KB)
-
Consolidated Financial Summary Fiscal 2019 Interim
(251KB)
-
Appendix to the Consolidated Financial Summary Fiscal 2019 Interim
(490KB)
-
Results Presentation Fiscal 2019 Interim
(740KB)
-
Summary of late-stage clinical trials
(227KB)
-
Revenues from other products
(23KB)
-
Transcript of Results Presentation Fiscal 2019 Interim (text)
(1,035KB)
